Immunoglobulin G4-related pancreatic and biliary diseases

Hisham Al-Dhahab, Julia McNabb-Baltar, Said Al-Busafi, Alan N. Barkun

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Background: Autoimmune pancreatitis and autoimmune cholangitis are new clinical entities that are now recognized as the pancreaticobiliary manifestations of immunoglobulin (Ig) G4-related disease. Objective: To summarize important clinical aspects of IgG4- related pancreatic and biliary diseases, and to review the role of IgG4 in the diagnosis of autoimmune pancreatitis (AIP) and autoimmune cholangitis (AIC). Methods: A narrative review was performed using the PubMed database and the following keywords: "IgG4", "IgG4 related disease", "autoimmune pancreatitis", "sclerosing cholangitis" and "autoimmune cholangitis". A total of 955 articles were retrieved; of these, 381 contained relevant data regarding the IgG4 molecule, pathogenesis of IgGrelated diseases, and diagnosis, management and long-term follow-up for patients with AIP and AIC. Of these 381 articles, 66 of the most pertinent were selected. Results: The selected studies demonstrated the increasing clinical importance of both AIP and AIC, which can mimic pancreatic cancer and cholangiocarcinoma, respectively. IgG4 titration in tissue or blood cannot be used alone to diagnose all IgG4-related diseases; however, it is often a useful adjunct to clinical, radiological and histological features. AIP and AIC respond to steroids; however, relapse is common and long-term maintenance treatment often required. Conclusions: A review of the diagnosis and management of both AIC and AIP is timely and pertinent to clinical practice because the amount of information regarding these conditions has increased substantially in the past few years, resulting in significant impact on the clinical management of affected patients.

Original languageEnglish
Pages (from-to)523-530
Number of pages8
JournalCanadian Journal of Gastroenterology
Volume27
Issue number9
Publication statusPublished - Sep 2013

Fingerprint

Pancreatic Diseases
Cholangitis
Pancreatitis
Immunoglobulins
Immunoglobulin G
Sclerosing Cholangitis
Cholangiocarcinoma
Disease Management
Pancreatic Neoplasms
PubMed
Autoimmune Diseases
Steroids
Databases
Recurrence

Keywords

  • Autoimmune cholangiopathy
  • Autoimmune pancreatitis
  • Cholangiocarcinoma
  • IgG4
  • IgG4-related disease
  • Pancreatic cancer

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Al-Dhahab, H., McNabb-Baltar, J., Al-Busafi, S., & Barkun, A. N. (2013). Immunoglobulin G4-related pancreatic and biliary diseases. Canadian Journal of Gastroenterology, 27(9), 523-530.

Immunoglobulin G4-related pancreatic and biliary diseases. / Al-Dhahab, Hisham; McNabb-Baltar, Julia; Al-Busafi, Said; Barkun, Alan N.

In: Canadian Journal of Gastroenterology, Vol. 27, No. 9, 09.2013, p. 523-530.

Research output: Contribution to journalReview article

Al-Dhahab, H, McNabb-Baltar, J, Al-Busafi, S & Barkun, AN 2013, 'Immunoglobulin G4-related pancreatic and biliary diseases', Canadian Journal of Gastroenterology, vol. 27, no. 9, pp. 523-530.
Al-Dhahab, Hisham ; McNabb-Baltar, Julia ; Al-Busafi, Said ; Barkun, Alan N. / Immunoglobulin G4-related pancreatic and biliary diseases. In: Canadian Journal of Gastroenterology. 2013 ; Vol. 27, No. 9. pp. 523-530.
@article{ac9192ce84a7490e90da9beac38e2b96,
title = "Immunoglobulin G4-related pancreatic and biliary diseases",
abstract = "Background: Autoimmune pancreatitis and autoimmune cholangitis are new clinical entities that are now recognized as the pancreaticobiliary manifestations of immunoglobulin (Ig) G4-related disease. Objective: To summarize important clinical aspects of IgG4- related pancreatic and biliary diseases, and to review the role of IgG4 in the diagnosis of autoimmune pancreatitis (AIP) and autoimmune cholangitis (AIC). Methods: A narrative review was performed using the PubMed database and the following keywords: {"}IgG4{"}, {"}IgG4 related disease{"}, {"}autoimmune pancreatitis{"}, {"}sclerosing cholangitis{"} and {"}autoimmune cholangitis{"}. A total of 955 articles were retrieved; of these, 381 contained relevant data regarding the IgG4 molecule, pathogenesis of IgGrelated diseases, and diagnosis, management and long-term follow-up for patients with AIP and AIC. Of these 381 articles, 66 of the most pertinent were selected. Results: The selected studies demonstrated the increasing clinical importance of both AIP and AIC, which can mimic pancreatic cancer and cholangiocarcinoma, respectively. IgG4 titration in tissue or blood cannot be used alone to diagnose all IgG4-related diseases; however, it is often a useful adjunct to clinical, radiological and histological features. AIP and AIC respond to steroids; however, relapse is common and long-term maintenance treatment often required. Conclusions: A review of the diagnosis and management of both AIC and AIP is timely and pertinent to clinical practice because the amount of information regarding these conditions has increased substantially in the past few years, resulting in significant impact on the clinical management of affected patients.",
keywords = "Autoimmune cholangiopathy, Autoimmune pancreatitis, Cholangiocarcinoma, IgG4, IgG4-related disease, Pancreatic cancer",
author = "Hisham Al-Dhahab and Julia McNabb-Baltar and Said Al-Busafi and Barkun, {Alan N.}",
year = "2013",
month = "9",
language = "English",
volume = "27",
pages = "523--530",
journal = "Canadian Journal of Gastroenterology and Hepatology",
issn = "2291-2789",
publisher = "Pulsus Group Inc.",
number = "9",

}

TY - JOUR

T1 - Immunoglobulin G4-related pancreatic and biliary diseases

AU - Al-Dhahab, Hisham

AU - McNabb-Baltar, Julia

AU - Al-Busafi, Said

AU - Barkun, Alan N.

PY - 2013/9

Y1 - 2013/9

N2 - Background: Autoimmune pancreatitis and autoimmune cholangitis are new clinical entities that are now recognized as the pancreaticobiliary manifestations of immunoglobulin (Ig) G4-related disease. Objective: To summarize important clinical aspects of IgG4- related pancreatic and biliary diseases, and to review the role of IgG4 in the diagnosis of autoimmune pancreatitis (AIP) and autoimmune cholangitis (AIC). Methods: A narrative review was performed using the PubMed database and the following keywords: "IgG4", "IgG4 related disease", "autoimmune pancreatitis", "sclerosing cholangitis" and "autoimmune cholangitis". A total of 955 articles were retrieved; of these, 381 contained relevant data regarding the IgG4 molecule, pathogenesis of IgGrelated diseases, and diagnosis, management and long-term follow-up for patients with AIP and AIC. Of these 381 articles, 66 of the most pertinent were selected. Results: The selected studies demonstrated the increasing clinical importance of both AIP and AIC, which can mimic pancreatic cancer and cholangiocarcinoma, respectively. IgG4 titration in tissue or blood cannot be used alone to diagnose all IgG4-related diseases; however, it is often a useful adjunct to clinical, radiological and histological features. AIP and AIC respond to steroids; however, relapse is common and long-term maintenance treatment often required. Conclusions: A review of the diagnosis and management of both AIC and AIP is timely and pertinent to clinical practice because the amount of information regarding these conditions has increased substantially in the past few years, resulting in significant impact on the clinical management of affected patients.

AB - Background: Autoimmune pancreatitis and autoimmune cholangitis are new clinical entities that are now recognized as the pancreaticobiliary manifestations of immunoglobulin (Ig) G4-related disease. Objective: To summarize important clinical aspects of IgG4- related pancreatic and biliary diseases, and to review the role of IgG4 in the diagnosis of autoimmune pancreatitis (AIP) and autoimmune cholangitis (AIC). Methods: A narrative review was performed using the PubMed database and the following keywords: "IgG4", "IgG4 related disease", "autoimmune pancreatitis", "sclerosing cholangitis" and "autoimmune cholangitis". A total of 955 articles were retrieved; of these, 381 contained relevant data regarding the IgG4 molecule, pathogenesis of IgGrelated diseases, and diagnosis, management and long-term follow-up for patients with AIP and AIC. Of these 381 articles, 66 of the most pertinent were selected. Results: The selected studies demonstrated the increasing clinical importance of both AIP and AIC, which can mimic pancreatic cancer and cholangiocarcinoma, respectively. IgG4 titration in tissue or blood cannot be used alone to diagnose all IgG4-related diseases; however, it is often a useful adjunct to clinical, radiological and histological features. AIP and AIC respond to steroids; however, relapse is common and long-term maintenance treatment often required. Conclusions: A review of the diagnosis and management of both AIC and AIP is timely and pertinent to clinical practice because the amount of information regarding these conditions has increased substantially in the past few years, resulting in significant impact on the clinical management of affected patients.

KW - Autoimmune cholangiopathy

KW - Autoimmune pancreatitis

KW - Cholangiocarcinoma

KW - IgG4

KW - IgG4-related disease

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84884400054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884400054&partnerID=8YFLogxK

M3 - Review article

C2 - 24078937

AN - SCOPUS:84884400054

VL - 27

SP - 523

EP - 530

JO - Canadian Journal of Gastroenterology and Hepatology

JF - Canadian Journal of Gastroenterology and Hepatology

SN - 2291-2789

IS - 9

ER -